Armen Shanafelt Net Worth & Insider Trades
Armen Shanafelt - Director, Aeglea Biotherapeutics, Inc
What is Armen Shanafelt's Net Worth?
The current estimated net worth of Aeglea Biotherapeutics, Inc's Director, Armen Shanafelt, is estimated to be about $25.46M . Armen Shanafelt owns about 150,000 units of Aeglea Biotherapeutics, Inc common stock. In the last 6 years at Aeglea Biotherapeutics, Inc, Armen Shanafelt has sold an estimated value of $0 worth.
What is Armen Shanafelt's Past Insider Trading?
Armen Shanafelt's largest purchase order was 150,000 units , worth over $549.69K on December 13, 2021. In total, Armen Shanafelt has made about 8 transactions over 6 years of their time at Aeglea Biotherapeutics, Inc. Armen Shanafelt usually trades in June, with the busiest year in 2021.
Armen Shanafelt
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Armen Shanafelt's' Mailing Address?
- Mailing address is C/o Lilly Ventures Fund I, Llc 115 W. Washington Street,ste 1680-South Indianapolis IN 46204 IN
Aeglea Biotherapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Anthony G. Quinn, M.B Ch.B, Ph.D. | 2020 | $538,000 | $2,089,861 | $2,089,861 | $25,745 | $2,909,606 |
| Anthony G. Quinn, M.B Ch.B, Ph.D. | 2019 | $518,000 | $1,663,919 | $1,663,919 | $53,857 | $2,482,776 |
| Charles N. York II | 2020 | $415,000 | $860,415 | $860,415 | $8,053 | $1,283,468 |
| Charles N. York II | 2019 | $390,000 | $522,424 | $522,424 | $7,712 | $1,085,136 |
| Leslie Sloan, Ph.D. | 2020 | $370,000 | $707,970 | $707,970 | $20,349 | $1,246,319 |
| Leslie Sloan, Ph.D. | 2019 | $355,000 | $632,380 | $632,380 | $19,843 | $1,149,223 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1636282/000156459021019953/agle-def14a_20210608.htm
What are Aeglea Biotherapeutics, Inc's Past Insider Trades?
Aeglea Biotherapeutics, Inc's most recent insider trade came on August 25, 2022 by Marcio Souza who bought 90,000 units worth $50.47K . In the last 6 years, insiders at Aeglea Biotherapeutics, Inc have sold an estimated value of $1.43M and bought an estimated value of $13.71M worth of shares. Insider trading is most common in June, with the busiest year in 2017, 2018 and 2022. The most active traders at the company are Anthony Quinn, President & CEO, Armen Shanafelt, Director, and Charles N. York II, Chief Financial Officer and VP .
Aeglea BioTherapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||